As much about hypoglycaemia remains unknown, the European research project Hypo-RESOLVE (Hypoglycaemia – Redefining SOLutions for better liVEs) aims to provide researchers and clinicians with more validated data about the condition by:
- Creating a sustainable clinical database;
- Conducting studies to better understand the underlying mechanisms of hypoglycaemia;
- Conducting a series of statistical analyses to define predictors and consequences of hypoglycaemia;
- Calculating the financial cost in European countries.
Hypo-RESOLVE has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 777460. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and T1D Exchange, JDRF, International Diabetes Federation (IDF), The Leona M. and Harry B. Helmsley Charitable Trust.
https://www.imi.europa.eu/
The communication here reflects the author's view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.
Company Details
- Founded
- -
- Address
- Brussels, Be
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://hypo-resolve.eu
- HQ
- Brussels
- Competitors
- DiaUnion, Athens LifeTech Park, MobilityGuard, INNODIA.
Hypo-Resolve Questions
Hypo-Resolve's website is https://hypo-resolve.eu
Hypo-Resolve's LinkedIn profile is https://be.linkedin.com/company/hypo-resolve
Hypo-Resolve's industry is
Research Services
Hypo-Resolve's categories are Research Services
Hypo-Resolve's founding year is 2018
